BR0009875A - Uso de n-acetilcisteìna para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise - Google Patents

Uso de n-acetilcisteìna para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise

Info

Publication number
BR0009875A
BR0009875A BR0009875-2A BR0009875A BR0009875A BR 0009875 A BR0009875 A BR 0009875A BR 0009875 A BR0009875 A BR 0009875A BR 0009875 A BR0009875 A BR 0009875A
Authority
BR
Brazil
Prior art keywords
preparation
patients
intravenous administration
acetylcysteine
prevent oxidative
Prior art date
Application number
BR0009875-2A
Other languages
English (en)
Inventor
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of BR0009875A publication Critical patent/BR0009875A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)

Abstract

"USO DE N-ACETILCISTEìNA PARA A PREPARAçãO DE UM MEDICAMENTO ADEQUADO PARA A ADMINISTRAçãO INTRAVENOSA PARA PREVENIR A CARGA OXIDATIVA EM PACIENTES QUE SOFRERAM DIáLISE". é descrito o uso de N-acetilcisteína para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise.
BR0009875-2A 1999-04-21 2000-04-18 Uso de n-acetilcisteìna para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise BR0009875A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000831A IT1312086B1 (it) 1999-04-21 1999-04-21 Uso della nac per la preparazione di un medicamento adatto allasomministrazione endovenosa per la prevenzione dello stress
PCT/EP2000/003485 WO2000064421A2 (en) 1999-04-21 2000-04-18 Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients

Publications (1)

Publication Number Publication Date
BR0009875A true BR0009875A (pt) 2002-04-09

Family

ID=11382781

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009875-2A BR0009875A (pt) 1999-04-21 2000-04-18 Uso de n-acetilcisteìna para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise

Country Status (11)

Country Link
US (2) US6627659B1 (pt)
EP (1) EP1171112A2 (pt)
JP (1) JP2002542279A (pt)
AU (1) AU771390B2 (pt)
BR (1) BR0009875A (pt)
CA (1) CA2369942A1 (pt)
HU (1) HU227537B1 (pt)
IL (2) IL146032A0 (pt)
IT (1) IT1312086B1 (pt)
NZ (1) NZ514911A (pt)
WO (1) WO2000064421A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
US20070232422A1 (en) * 2006-03-30 2007-10-04 Jung-Shih Chang Baseball bat with a break resistant structure
BG66222B1 (bg) * 2006-06-08 2012-06-29 "Унифарм" Ад Диализен състав
US20100204328A1 (en) * 2006-06-22 2010-08-12 Reinhold Deppisch Solution and Method to Reduce, Treat and/or Prevent Oxidative Stress and Cell Activation
CN102526237B (zh) * 2012-01-21 2014-06-25 南方医科大学南方医院 用于清除晚期氧化蛋白终产物的药物组合物及其用途
CA2956325C (en) * 2014-07-25 2023-09-26 Bloodworks Determination of small-molecule thiols and disulfides: protein bound cys and total cysteine as biomarkers of oxidative stress
IT201900002919A1 (it) * 2019-02-28 2020-08-28 Solongevity Nutraceuticals S R L Composizione antiossidante

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216506D0 (en) 1992-08-04 1992-09-16 Rice Evans Catherine A Improvements in or relating to the treatment of sickle cell disease
DE69623779T2 (de) 1995-05-05 2003-01-30 Essex Specialty Prod Elektrisch betätigte abgabepistole und abgabeverfahren
ES2114817B1 (es) * 1996-05-16 1999-02-16 Zambon S A Asociacion farmacologica entre n-acetilcisteina y levulosa para la prevencion de la muerte celular y enfermedades asociadas.
US5912019A (en) 1997-02-07 1999-06-15 Musc Foundation For Research Development Compounds for reducing ischemia/reperfusion injury

Also Published As

Publication number Publication date
JP2002542279A (ja) 2002-12-10
US20030139472A1 (en) 2003-07-24
ITMI990831A1 (it) 2000-10-21
HU227537B1 (en) 2011-08-29
IL146032A (en) 2007-05-15
IT1312086B1 (it) 2002-04-04
CA2369942A1 (en) 2000-11-02
WO2000064421A3 (en) 2001-10-11
AU4401200A (en) 2000-11-10
NZ514911A (en) 2004-03-26
IL146032A0 (en) 2002-07-25
AU771390B2 (en) 2004-03-18
WO2000064421A2 (en) 2000-11-02
US6627659B1 (en) 2003-09-30
EP1171112A2 (en) 2002-01-16
HUP0200861A3 (en) 2003-04-28
HUP0200861A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
BR0108435A (pt) Formulação e uso de entecavir de baixa dose
TR200001891T2 (tr) ASPB28- İnsan ensülini ve kullanımı.
CR6458A (es) Composiciones de valdecoxib
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
IT1256651B (it) Composizione farmaceutica a rilascio controllato in sospensione liquida
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
HUP0102489A2 (hu) Biokémiai anyagok alkalmazása emberi test szerveiben található simaizomsejtek összehúzódása okozta egészségi állapotok megelőzésére és kezelésére alkalmas készítményekben
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
BR9916860A (pt) Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma
KR970025615A (ko) 암 전이 억제제
TR200101633T2 (tr) Farmasötik bileşim
BR0009875A (pt) Uso de n-acetilcisteìna para a preparação de um medicamento adequado para a administração intravenosa para prevenir a carga oxidativa em pacientes que sofreram diálise
ITMO20000124A0 (it) Dispositivo medicale preassemblato monouso per la somministrazione a pazienti di almeno due medicamenti in proporzioni prestabilite
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
RS52011B (sr) Nova primena derivata taksoida
GEP20043202B (en) Resorcinol Derivatives
BR0009380A (pt) Tratamento de câncer melhorado comtemozolomida
UY26595A1 (es) Formulaciones de entecavir de dosis bajas y uso
BR0108261A (pt) Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono
BR0213410A (pt) Usos farmacêuticos de bisfosfonatos
BR0208920A (pt) Inibidor de aromatase em dose única para tratamento de infertilidade
BR0007513A (pt) Fosfatidilinositóis sulfatados, sua preparação euso

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/198, A61K 31/00, A61P 13/00

Ipc: A61K 31/00 (2009.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.